Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.49 |
| ▸ | NPC1 | O15118 | 5/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.49 |
| ▸ | APP | P05067 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 2/20 | 0.41 |
| ▸ | ILK | Q13418 | 1/20 | 0.40 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20681327 | 0.79 | DYRK1A (0.42) | CYP3A4CYP2C9DYRK1AAPPMAPT | |
| SCHEMBL146303 | 0.79 | SMN1; SMN2 (0.56) | RAB9ANPC1APPMAPTALDH1A1 | |
| SCHEMBL12872411 | 0.79 | RAB9A (0.56) | RAB9ANPC1DYRK1AAPPMAPT | |
| SCHEMBL12312853 | 0.79 | NPC1 (0.56) | RAB9ANPC1DYRK1AAPPMAPT | |
| SCHEMBL19190176 | 0.79 | APP (0.44) | RAB9ANPC1CYP3A4CYP2C9DYRK1A | |
| SCHEMBL140656 | 0.79 | HTT (0.56) | DYRK1AAPPMAPTHTT | |
| SCHEMBL29409281 | 0.79 | HTT (0.56) | DYRK1AAPPMAPTHTT | |
| SCHEMBL7548821 | 0.79 | GFER (0.56) | RAB9ANPC1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL9796864 | 0.78 | PSMB8 (0.44) | RAB9ANPC1CYP3A4DYRK1AAPP | |
| SCHEMBL15950041 | 0.78 | RAB9A (0.41) | RAB9ANPC1CYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2305690-B1 | Signalling compounds for use in methods of detecting hydrogen peroxide | LUMIGEN INC (US) | 2012-08-29 | — | — | EP | disclosed |
| US-8137990-B2 | Compositions for chemiluminescent detection of hydrogen peroxide | LUMIGEN, INC. (US) | 2012-03-20 | — | — | US | disclosed |
| EP-2305690-A1 | Signalling compounds for use in methods of detecting hydrogen peroxide | LUMIGEN, INC. (US) | 2011-04-06 | — | — | EP | disclosed |
| US-7704752-B2 | Signalling compounds for use in methods of detecting hydrogen peroxide | LUMIGEN, INC. (US) | 2010-04-27 | — | — | US | disclosed |
| US-20100055800-A1 | Compositions for Chemiluminescent Detection of Hydrogen Peroxide | LUMIGEN, INC. (US) | 2010-03-04 | — | — | US | disclosed |
| US-20080261318-A1 | Signalling Compounds For Use In Methods Of Detecting Hydrogen Peroxide | LUMIGEN, INC. (US) | 2008-10-23 | — | — | US | disclosed |
| US-7390670-B2 | Signalling compounds and methods for detecting hydrogen peroxide | LUMIGEN, INC. (US) | 2008-06-24 | — | — | US | disclosed |
| EP-1594855-A4 | SIGNALLING COMPOUNDS FOR USE IN METHODS OF DETECTING HYDROGEN PEROXIDE | LUMIGEN INC (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1594855-A2 | SIGNALLING COMPOUNDS FOR USE IN METHODS OF DETECTING HYDROGEN PEROXIDE | LUMIGEN, INC. (US) | 2005-11-16 | — | — | EP | disclosed |
| US-6919463-B2 | Signalling compounds for use in methods of detecting hydrogen peroxide | LUMIGEN, INC. (US) | 2005-07-19 | — | — | US | disclosed |
| WO-2004074810-A2 | SIGNALLING COMPOUNDS FOR USE IN METHODS OF DETECTING HYDROGEN PEROXIDE | LUMIGEN INC. (US) | 2004-09-02 | — | — | WO | disclosed |
| US-20040171098-A1 | Signalling compounds for use in methods of detecting hydrogen peroxide | LUMIGEN INC. | 2004-09-02 | — | — | US | disclosed |
| US-20040166539-A1 | Signalling compounds and methods for detecting hydrogen peroxide | LUMIGEN, INC. | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171098-A1 | Signalling compounds for use in methods of detecting hydrogen peroxide | LPO, HAO2, HAO1 | RAB9A 3294/4885NPC1 4326/4885CYP1A2 530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.